Edesa BiotechEDSA
13F holders, Q2 2026 (June 30)33holders +5
11new positions
6sold out
1famous investor
$7.99avg. 13F price*
At the end of Q2 2026, 33 institutions reported holding Edesa Biotech Inc. (EDSA) in their 13F filings, up 5 from Q1 2026. 11 opened new positions and 6 sold out. The largest holders were Velan Capital Investment Management LP ($6.7M), Rubric Capital Management LP ($5.4M) and Perceptive Advisors LLC ($4.6M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Edesa Biotech Inc.
- CUSIP
- 27966L306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $6.9M |
| Exits | 6 | $585K |
All 13F filers, Q1 2026 → Q2 2026: 1,289,799 shares bought and 178,997 shares sold, net +1,110,802 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Velan Capital Investment Management LP | 4.12% | No change | 827,500 | $6.7M |
| Rubric Capital Management LP | 0.05% | Reduce -2.6% | 669,500 | $5.4M |
| Perceptive Advisors LLC | 0.07% | No change | 563,239 | $4.6M |
| Millennium Management | 0.00% | New | 561,751 | $4.6M |
| Stonepine Capital Management, LLC | 2.43% | Add +1421.5% | 456,439 | $3.2M |
| Boxer Capital Management, LLC | 0.13% | New | 205,000 | $1.7M |
| Vanguard Capital Management LLC | 0.00% | Reduce -4.8% | 81,839 | $665K |
| Geode Capital Management, LLC | 0.00% | Add +5.0% | 80,879 | $658K |
| Jane Street Group, LLC | 0.00% | Reduce -37.4% | 72,465 | $589K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.7% | 38,718 | $315K |
| State Street Corp. | 0.00% | No change | 37,979 | $309K |
| XTX Topco Ltd | 0.00% | New | 35,352 | $287K |
| HRT Financial LP | 0.00% | New | 31,531 | $256K |
| BlackRock, Inc. | 0.00% | Reduce -0.8% | 27,495 | $224K |
| Northern Trust Corp. | 0.00% | No change | 14,994 | $122K |
| Scotia Capital Inc. | 0.00% | Reduce -9.2% | 14,393 | $117K |
| Two Sigma Investments, LP | 0.00% | New | 14,032 | $114K |
| UBS Group AG | 0.00% | Add +188.7% | 6,763 | $55K |
| SBI Securities Co., Ltd. | 0.00% | Add +0.1% | 3,505 | $28K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 2,595 | $21K |
| Royal Bank of Canada | 0.00% | Add +11.6% | 1,851 | $15K |
| McGuire Capital Advisors Inc. | 0.01% | No change | 1,500 | $12K |
| Morgan Stanley | 0.00% | New | 1,400 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +142.6% | 1,230 | $10K |
| BNP Paribas Financial Markets | 0.00% | New | 1,122 | $9K |
| JPMorgan Chase & Co. | 0.00% | New | 1,130 | $9K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 162 | $1K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 142 | $1K |
| Banque Cantonale Vaudoise | 0.00% | No change | 3 | $1K |
| Jones Financial Companies LLLP | 0.00% | New | 8 | $66 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 4 | $33 |
| Danske Bank A/S | 0.00% | No change | 1 | $8 |
| LRI Investments, LLC | 0.00% | No change | 1 | $8 |
"% of holder's portfolio" is EDSA's weight in each manager's 13F, not the share of Edesa Biotech Inc. the manager owns.